Subscribe to Newsletter

Isotachophoresis Improves Nucleic Acid Extraction and Purification from FFPE Samples

Overview

Formalin-fixed, paraffin-embedded (FFPE) tissue remains the preferred method of tissue preservation for clinical specimens. Compared to other methods of tissue preservation, FFPE samples are relatively stable at room temperature. This enables FFPE samples to be stored for long periods of time without the need for expensive refrigeration equipment or large amounts of facility space. For histological or morphological analyses, FFPE samples can be easily sectioned and stained to visualize both morphological and molecular features to identify disease states. Nucleic acids within the preserved tissue can be extracted and purified for downstream applications using PCR, quantitative PCR (qPCR) and next-generation sequencing (NGS). For these reasons and more, clinicians and researchers will likely continue to depend on the analysis of genetic material obtained from FFPE samples for years to come.

To use FFPE samples for molecular analysis, researchers are faced with several challenges. Formalin fixation, the process used to generate FFPE samples, is not standardized and can introduce greater variation across samples prepared by different clinicians or at different times. Studies conducted more than 20 years ago found that the condition of the tissue sample, mode of formalin use, and time of fixation can all affect the integrity of nucleic acids, which can compromise downstream analysis1. Furthermore, the buffers used during the fixation process can lead to the deamination of cytosine bases and single nucleotide modifications2. Fixation also induces cross-linking of nucleic acids with proteins as well as to other nucleic acids. To address cross-linking and deamination, samples must be treated in various ways to remove paraffin and reverse cross-linking while avoiding additional damage prior to nucleic acid extraction. These treatments, while necessary to obtain high-quality nucleic acid for molecular analysis, are time-consuming and do not address any fragmentation that may have occurred.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register